Physiological, kinematic, and electromyographic responses to kinesiology-type patella tape in elite cyclists by Hébert-Losier, Kim et al.
1 
 
Physiological, kinematic, and electromyographic responses to kinesiology-type patella 1 
tape in elite cyclists 2 
 3 
Kim Hébert-Losiera*, Ngieng Siew Yinb, C. Martyn Beavena, Chris Tee Chow Lib, and Jim 4 
Richardsc 5 
 6 
aFaculty of Health, Sport and Human Performance, University of Waikato, Tauranga, New 7 
Zealand 8 
 9 
bDepartment of Sports Science, National Sports Institute of Malaysia, Kuala Lumpur, 10 
Malaysia 11 
 12 
bSchool of Health Sciences, University of Central Lancashire, Preston, Lancashire, United 13 
Kingdom 14 
 15 
*Corresponding Author: Kim Hébert-Losier, 16 
e-mail: kim.hebert-losier@waikato.ac.nz 17 
 18 
Keywords: 3D analysis; biomechanics; electromyography; kinesiology; performance; 19 
physiology 20 
 21 
CONFLICT OF INTEREST 22 
None. 23 
 24 
FINANCIAL DISCLOSURE 25 
None. 26 
27 
2 
 
ABSTRACT 28 
 29 
Kinesiology-type tape (KTT) has become popular in sports for injury prevention, 30 
rehabilitation, and performance enhancement. Many cyclists use patella KTT; however, its 31 
benefits remain unclear, especially in uninjured elite cyclists. We used an integrated 32 
approach to investigate acute physiological, kinematic, and electromyographic responses to 33 
patella KTT in twelve national-level male cyclists. Cyclists completed four, 4-minute 34 
submaximal efforts on an ergometer at 100 and 200 W with and without patella KTT. 35 
Economy, energy cost, oxygen cost, heart rate, efficiency, 3D kinematics, and lower-body 36 
electromyography signals were collected over the last minute of each effort. Comfort levels 37 
and perceived change in knee stability and performance with KTT were recorded. 38 
The effects of KTT were either unclear, non-significant, or clearly trivial on all collected 39 
physiological and kinematic measures. KTT significantly, clearly, and meaningfully 40 
enhanced vastus medialis peak, mean, and integrated electromyographic signals, and vastus 41 
medialis-to-lateralis activation. Electromyographic measures from biceps femoris and 42 
biceps-to-rectus femoris activation ratio decreased in either a significant or clinically 43 
meaningful manner. Despite most cyclists perceiving KTT as comfortable, increasing 44 
stability, and improving performance, the intervention exerted no considerable effects on all 45 
physiological and kinematic measures. KTT did alter neuromuscular recruitment, which has 46 
potential implications for injury prevention.  47 
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INTRODUCTION 48 
Many health professionals, athletes, and coaches use kinesiology-type tape (KTT), with the 49 
intent to manage musculoskeletal sport injuries; however, growing evidence suggests no 50 
additional benefit from KTT application compared to placebo taping or active control 51 
treatment methods when managing musculoskeletal conditions (Ouyang et al., 2018, 52 
Williams et al., 2012). On the other hand, several beneficial effects from KTT application 53 
have been reported, including enhancement in muscle activation (Gilleard et al., 1998); 54 
improved biomechanics, joint, and patella alignment (Lyman et al., 2017, Merino-Marban et 55 
al., 2013); and decreased pain (Bockrath et al., 1993, Merino-Marban et al., 2013). It is 56 
worth noting, however, that many studies report no effect from KTT on these measures 57 
(Halski et al., 2015) or athletic performance (Lins et al., 2013, Reneker et al., 2018). 58 
Underlying reasons for such contrasting scientific findings likely include the varied 59 
application methods, differences in the mechanical properties of KTT across brands 60 
(Matheus et al., 2017), targeted population, and individuals’ perceived benefits of KTT with 61 
a potential for placebo effect (Mak et al., 2018) .  62 
 63 
Cycling is a popular recreational and competitive sporting activity worldwide, and a 64 
common exercise modality used during rehabilitation. At an elite level, athletes and coaches 65 
continually seek for ways to improve performance through marginal gains and prevent the 66 
occurrence of injuries. KTT is routinely used by coaches and athletes as an ergogenic aid 67 
(Reneker et al., 2018), with various forms of taping employed to prevent injury occurrence 68 
or recurrence (Zech and Wellmann, 2017). Given that up to 94% of professional cyclists 69 
suffer from at least one overuse injury annually (Silberman, 2013), the visible increase in 70 
use of KTT amongst elite cyclists for prophylactic purposes is not surprising. 71 
 72 
Taping or bracing are frequently used to alleviate patellofemoral pain (PFP) symptoms and 73 
can impact knee motion during cycling (Theobald et al., 2012). Non-specific KTT 74 
application has been shown to be as effective as specific application for reducing pain and 75 
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inducing significant changes in lower-body cycling biomechanics in a symptomatic 76 
population group (Theobald et al., 2014). However, any potential positive effect of taping on 77 
energy cost of cycling, neuromuscular recruitment patterns, and performance of 78 
asymptomatic high-level cyclists has not been examined, despite the visibly increased 79 
prevalence of use in the cycling community and KTT marketing campaigns. 80 
 81 
Using an integrated approach, our aim was therefore to investigate the acute physiological, 82 
kinematic, and electromyographic outcomes in response to applying KTT to the knee of elite 83 
cyclists. As perceptions may influence outcomes of interventions, individual perceptions 84 
were also assessed. We hypothesised that taping would be accompanied by changes in 85 
muscle recruitment patterns, cycling economy and efficiency, and perceived stability that 86 
have the potential to modulate cycling performance.  87 
 88 
MATERIALS & METHODS 89 
Participants   90 
All male cyclists of the National Cycling Team training at the National Sports Institute for 91 
Malaysia (n = 12) were invited and accepted to participate in this study. These 12 national 92 
cyclists (mean ± standard deviation (SD): age, 21.7 ± 2.8 years; body mass, 65.6 ± 5.4 kg; 93 
and height, 172.7 ± 3.4 cm) with at least four years of training experience provided written 94 
informed consent to participate in this study, which adhered to The Code of Ethics of the 95 
World Medical Association (Declaration of Helsinki) and was approved by our Institutional 96 
Ethical Review Board (ISNRP 29/2015). Inclusion criteria were cyclists training at the 97 
National Sports Institute of Malaysia for the National Cycling Team, good self-reported 98 
general health, and at least 18 years of age. Cyclists with current or recent (< 1 month) 99 
musculoskeletal injuries, joint pathologies, or medical contraindications to physical exertion 100 
were excluded.  101 
 102 
Design 103 
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All cyclists attended 3 sessions at the biomechanics laboratory of the National Sports 104 
Institute of Malaysia, one week apart. The first two weeks were familiarization sessions and 105 
the third week was used to investigate the acute effects of KTT application through a 106 
repeated-measures randomized experimental study design. 107 
 108 
Given that ergometer versus outdoor cycling can affect cycling physiological measures 109 
(Bertucci et al., 2012) and pedalling biomechanics (Bertucci et al., 2007), cyclists brought 110 
their road bikes to the laboratory the first week of testing. Bike setup parameters were 111 
recorded and employed to individualize setup on a Lode cycling ergometer (Excalibur Sport, 112 
Lode B.V., Groningen, Netherlands), with all cyclists using their habitual cleats. The final 113 
ergometer setup was recorded and used across the three weeks. Baseline demographics, 114 
including leg dominance (self-perceived stronger cycling side), were recorded. Body mass 115 
(kg) was measured weekly and subsequently used to calculate relative physiological 116 
variables. 117 
 118 
Cyclists began all sessions with a 2-min cycling warm-up on the ergometer after being set-119 
up with the monitoring equipment. Cyclists then performed a submaximal 4-minute cycling 120 
effort at 100 W, followed immediately by a second submaximal 4-minute cycling effort at 121 
200 W. The efforts were completed without KTT during the familiarization weeks, and 122 
twice on the third week: once with and once without KTT. The no tape (NT) and KTT 123 
conditions were completed in a block-randomized order and separated by a 5-minute passive 124 
seated rest. Thus, all cyclists completed four 4-minute efforts: NT 100 W, NT 200 W, KTT 125 
100 W, and KTT 200 W. The powers of 100 and 200 W were selected to ensure that cycling 126 
efforts were below the anaerobic threshold and to compute delta efficiency (Coyle et al., 127 
1992) (see Physiology). Furthermore, the application of patella KTT at these powers has 128 
been shown to alter lower-body cycling biomechanics in previous studies (Theobald et al., 129 
2014), with these power levels set alongside the National Cycling Team of Malaysia to 130 
inform their practice and use of KTT application in longer steady-state riding situations. 131 
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 132 
Taping method 133 
The taping application we used was based on a method previously reported to induce 134 
changes in cycling biomechanics within the power ranges here examined (Theobald et al., 135 
2012, Theobald et al., 2014). With cyclists seated on the ergometer with the leg at the 136 
bottom of their power stroke , a strip of KTT (RockTape™, RockTape Inc., California) of 137 
length equal to 50% of individual knee circumference was applied on to the centre of the 138 
patella with light tension (approximately 25% of stretch to the tape). The medial and lateral 139 
tape edges were aligned with the medial and lateral knee-joint lines (Figure 1). The same 140 
experienced physiotherapist applied the tape to all cyclists. This simple KTT method (i.e., 141 
across the patella) was selected given its ease-of-use and findings from previous studies 142 
indicating that such a method impacts cycling biomechanics in a manner that is comparable 143 
to that of a more intricate KTT application method (Theobald et al., 2014). Given the 144 
minimalist KTT method applied, a “placebo” taping method was not implemented. 145 
***Insert Figure 1*** 146 
 147 
Physiology  148 
Oxygen consumption (VO2), carbon dioxide output (VCO2), and heart rate were monitored 149 
throughout the 4-minute experimental efforts using a calibrated K5 wearable metabolic 150 
technology system (COSMED, Rome, Italy). All physiological measures were averaged over 151 
the last minute where steady state was observed. VO2 was used to determine steady-state 152 
relative oxygen cost (mL/kg/km) and absolute cycling economy (W/L/min). From the VO2 153 
and CO2 data, the relative energy cost of efforts (kcal/kg/km) was estimated using the energy 154 
expenditure equations described by Jeukendrup and Wallis (2005). Gross efficiency (%) and 155 
delta efficiency (%) were calculated as suggested by Coyle et al. (1992) using the ratio of 156 
work accomplished (watts converted to kcal/min) to absolute energy cost (kcal/min) for 157 
gross efficiency, and the reciprocal of the slope that describes the relationship between the 158 
absolute energy cost and work accomplished for delta efficiency.  159 
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 160 
Kinematics  161 
Lower-body, trunk, and pelvis movements were captured in 3D during the last minute of 162 
each 4-minute cycling effort at 300 Hz using 10 Oqus 300 infrared cameras and the Qualisys 163 
Track Manager Software version 2.12 (Qualisys AB, Gothenburg, Sweden). Forty-six retro-164 
reflective markers (12 mm in diameter) were affixed to the skin, clothes, and shoes of 165 
cyclists based on the Calibrated Anatomical System Technique (Cappozzo et al., 1997) and 166 
following established guidelines (Grood and Suntay, 1983). All 46 markers were used for 167 
static calibration; whereas 14 markers were removed for the cycling efforts (Figure 2).  168 
 169 
***Insert Figure 2*** 170 
 171 
An 8-segment biomechanical model with 6 degrees of freedom at each joint was constructed 172 
in Visual3D Professional™ Software version 5.02.30 (C-Motion Inc., Germantown, MD, 173 
USA), with the local coordinates of the trunk, pelvis, thighs, shanks, and feet derived from 174 
the static calibration and the pelvis used to define hip-joint centres (Bell et al., 1989). Prior 175 
to each session, the measurement volume was calibrated using a 750-mm wand and L-frame 176 
that defined the Cartesian origin of the laboratory. Cyclists were then requested to sit on the 177 
saddle of the ergometer, with legs hanging to the side, and remain motionless to allow static 178 
calibration.  179 
 180 
Electromyography 181 
The electromyography (EMG) signals from the following four muscles were recorded on 182 
both the dominant and non-dominant sides: vastus medialis (VM), vastus lateralis (VL), 183 
rectus femoris (RF) and biceps femoris (BF). Signals were recorded using Noraxon’s Dual 184 
EMG surface Ag/AgCl electrodes (17.5 mm inter-electrode distance), wireless EMG 185 
sensors, and Desktop DTS data logger (Noraxon USA Inc., Scottsdale, AZ). EMG data were 186 
sampled at 1500 Hz, low-pass filtered at 500 Hz, and digitally integrated through the 187 
8 
 
Qualisys Track Manager Software. Skin preparation and electrode positioning followed the 188 
Surface EMG for Noninvasive Assessment of Muscle (Hermens et al., 2000), International 189 
Society of Electrophysiology and Kinesiology (Merletti and di Torino, 1999), and published 190 
protocols (Gilleard et al., 1998). Cyclists completed a few cycling revolutions before 191 
experimentation to allow visual inspection of EMG signal quality. Sensors were checked and 192 
reapplied if artefacts were observed. 193 
 194 
Perception 195 
Perceived change in knee stability and performance with KTT compared to NT was assessed 196 
at the end of the experimental session using a 5-point Likert (1932) Scale from negative (1) 197 
to positive (5) perception, with the mid-point value representing no change (3). Comfort 198 
level of KTT was also assessed using a similar method. Anchor points ranged from very 199 
uncomfortable (1), much less stable (1), and much worse (1) to very comfortable (5), much 200 
more stable (5), and much better (5) for comfort, knee stability, and performance, 201 
respectively.  202 
 203 
Data processing 204 
Kinematic and EMG data were exported to the C3D format and processed in Visual 3D. 205 
Marker data were filtered using a 4th order zero-lag 15 Hz Butterworth bidirectional filter. 206 
Kinematic parameters were then calculated using rigid-body analysis and Euler angles 207 
obtained from the static calibration. Hip, knee, and ankle angles in the sagittal (flexion-208 
extension), coronal (adduction-abduction), and transverse (internal-external rotation) planes 209 
were calculated using an x-y-z Cardan sequence equivalent to the Joint Coordinate System 210 
(Grood and Suntay, 1983), with the pelvis angles in the sagittal (anterior-posterior), coronal 211 
(dominant, non-dominant obliquity), and transverse (dominant, non-dominant rotation) 212 
planes defined relative to the laboratory. Trunk angles in the sagittal (flexion-extension), 213 
coronal (dominant, non-dominant lateral flexion), and transverse (dominant, non-dominant 214 
rotation) planes were also defined in relation to the laboratory coordinates. Data were 215 
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divided into movement cycles and time-normalized based on maximal knee flexion events. 216 
Ensemble-average kinematic curves were generated for each participant and cycling effort, 217 
and range of motion (ROM) values extracted. 218 
 219 
EMG signal data were zeroed to remove any baseline offset and a 20-Hz high-pass filter 220 
applied to remove movement artefacts. Signals were subsequently rectified and linear 221 
envelopes generated by smoothing the data using a low-pass, 4th order, zero-lag 15 Hz 222 
Butterworth filter. The linear envelope for each muscle was then normalized to the highest 223 
observed signal across all four conditions examined (% max). Similar to the kinematic data, 224 
ensemble-average EMG signal curves time normalized to maximal knee flexion events were 225 
generated from which mean and peak EMG signal values were extracted. An integrated 226 
EMG (iEMG) signal was also generated by integrating the linear envelop from the start to 227 
the end of each movement cycle, which was then normalized to the maximal observed iEMG 228 
across all four efforts (% max).  229 
 230 
Statistical analysis 231 
Mean and SD values were computed for all parameters for both the 100 and 200 W efforts 232 
and dominant and non-dominant sides. Changes in mean (Δmean) and standardized effect 233 
sizes (ES) were computed to quantify the acute effect of KTT; with ES considered small, 234 
moderate, large, and very large when reaching thresholds of 0.2, 0.6, 1.2, 2.0, and trivial 235 
when < 0.2 (Smith and Hopkins, 2011). An effect was deemed ‘clear’ when its 90% 236 
confidence limit did not overlap the thresholds for small positive and small negative effects 237 
(i.e., 5%); and ‘likely’ to be clinically meaningful when its probability exceeded 75% (Smith 238 
and Hopkins, 2011).  239 
 240 
Paired t-tests were used to investigate differences between the tape and no-tape condition for 241 
the measures of interest, with the threshold for statistical significance set at P ≤ 0.05. All 242 
10 
 
data were analysed using customized statistical spreadsheets (Microsoft Excel 2013, 243 
Microsoft Corp, Redmond WA, USA).   244 
 245 
RESULTS 246 
Physiology 247 
KTT had clear and trivial effects on oxygen cost and energy cost measures at 200 W that did 248 
not reach statistical significance. The effect of KTT on all other physiological parameters 249 
was unclear or unlikely, and not statistically significant (Table 1).  250 
 251 
***Insert Table 1*** 252 
 253 
Kinematics 254 
The clear and likely effects of KTT on ROM values at 100 W (Table 2) and 200 W (Table 255 
3) were trivial, except for the mean ankle ROM in the transverse plane at 100 W on the 256 
dominant side, where a small non-significant increase was noted (ES, 0.35; P, 0.097; Table 257 
2). In all other cases, the effect of KTT was unclear or unlikely, and not statistically 258 
significant.  259 
 260 
***Insert Table 2*** 261 
 262 
***Insert Table 3*** 263 
 264 
Electromyography 265 
The effect of KTT on certain VM, VM-to-VL ratio, BF, and RF-to-BF ratio measures were 266 
clear, likely, and significant at 100 W (Table 4) and 200 W (Table 5). Changes primarily 267 
affected the efforts performed at 100 W.  268 
 269 
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At 100 W, the effect of KTT on the non-dominant side was clear, likely, and significant for 270 
increasing VM peak (ES, 1.35; P, 0.044), and decreasing the RF-to-BF ratio peak (ES, -0.42; 271 
P, 0.021) and mean (ES, -0.62; P, 0.016) measures. There was also clear and likely non-272 
significant increases in VM iEMG (ES, 0.72; P, 0.128); and VM-to-VL ratio peak (ES, 2.20; 273 
P, 0.118), iEMG (ES, 1.26; P, 0.097), and mean (ES, 1.21; P, 0.08) measures. 274 
 275 
At 100 W, the effect of KTT on the dominant side was clear, likely, and significant for 276 
increasing VM iEMG (ES, 0.98; P, 0.024) and mean (ES, 0.95; P, 0.030); increasing VM-to-277 
VL ratio peak (ES, 2.19; P, 0.009), iEMG (ES, 1.63; P, 0.020), and mean (ES, 1.21; P, 278 
0.029); and decreasing BF mean (ES, -0.36; P, 0.047) measures. There was also a clear and 279 
likely non-significant increase in VM peak (ES, 0.87; P, 0.056); and decrease in RF peak 280 
(ES, -0.39; P, 0.135) and mean (ES, -0.51; P, 0.137) measures. 281 
 282 
***Insert Table 4*** 283 
 284 
At 200 W, the effect of KTT on the non-dominant side was clear, likely, and significant for 285 
increasing VM iEMG (ES, 1.04; P, 0.014). There was also a clear and likely non-significant 286 
increase in VM peak (ES, 0.92; P, 0.122) and mean (ES, 0.92; P, 0.088); increase in VM-to-287 
VL ratio peak (ES, 1.41; P, 0.157), iEMG (ES, 0.88; P, 0.124), and mean (ES, 2.07; P, 288 
0.098); and decrease in BF mean (ES, -0.39; P, 0.194). At 200 W, there was a clear and 289 
likely non-significant effect of KTT on decreasing peak BF (ES, -0.69; P, 0.077) measures. 290 
 291 
***Insert Table 5*** 292 
 293 
Perception 294 
Most cyclists perceived KTT as being comfortable, providing additional stability to the 295 
knee, and enhancing performance (Figure 3). However, three cyclists felt that KTT was 296 
uncomfortable, with one cyclist feeling more unstable with KTT.  297 
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 298 
***Insert Figure 3***  299 
 300 
DISCUSSION 301 
Despite most cyclists perceiving enhanced performance and knee stability with patella KTT; 302 
the effects of the intervention were either unclear, non-significant, or clearly trivial for all 303 
physiological and kinematic measures, except for a small non-significant increase in ankle 304 
ROM on the dominant side in the transverse plane at 100 W. KTT affected the EMG-305 
determined muscle activation patterns the most, notably increasing  VM and VM-to-VL ratio 306 
measures at both powers; and decreasing BF and RF-to-BF ratio measures. Overall, our 307 
findings indicate a potential for patella KTT to alter the neuromuscular recruitment patterns 308 
of elite cyclists with no current musculoskeletal injury at low powers, which could have 309 
implications in the prevention of overuse injuries. 310 
 311 
Physiology 312 
Cycling biomechanics and neuromuscular function can alter energy cost, oxygen cost, and 313 
cycling efficiency. For instance, cycling in a more aerodynamic than upright position can 314 
increase oxygen cost by 1.5% (Gnehm et al., 1997). This increase is speculated to result in 315 
part from a shift in mean hip-joint angles towards greater flexion, which alters the operating 316 
points of the hip- and knee-joint muscles on the force-velocity and force-length curves, as 317 
well as an increase in hip adductor activation to prevent out-of-plane motion in extreme hip 318 
flexion. The biomechanical and neuromuscular differences associated with changing cycling 319 
positions from aerodynamic to upright are inherently much larger than those potentially 320 
resulting from KTT application, especially proximally at the trunk, pelvis, and hip (Dorel et 321 
al., 2009). It is likely that the neuromuscular changes observed here in VM, VM-to-VL ratio, 322 
BF, and RF-to-BF ratio measures with KTT were not sufficient to cause significant or clear 323 
alterations in the physiological parameters monitored.  324 
 325 
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Kinematics and muscle activation 326 
Ideally, the legs should act as pistons during cycling (Sanner and O'Halloran, 2000), with 327 
lower-body motion mainly directed upwards and downwards, and cyclists in a saddle 328 
position that allows knee extension with minimal valgus angulation. Most studies addressing 329 
lower-body kinematics during cycling have focused on sagittal plane motion, with our 330 
sagittal ROM values agreeing with those typically reported (Bini et al., 2011). Although a 331 
certain amount of ‘out-of-plane’ motion is anticipated, lower-body misalignment and 332 
excessive out-of-plane motion are reported to contribute to musculoskeletal injuries in 333 
cyclists (Bini et al., 2011, Gregor and Wheeler, 1994). One of the proposed benefits of KTT 334 
is to assist in joint alignment through improvements in proprioception, which in turn can 335 
improve movement patterns and cycling efficiency. Hence, we anticipated less out-of-plane 336 
motion at the knee with KTT; however, such a reduction was not evident.  337 
 338 
Previous studies have shown that patellar taping can affect movement patterns in both 339 
healthy and symptomatic individuals (Theobald et al., 2014), as well as muscle recruitment 340 
of VM (Gilleard et al., 1998), VL (Gilleard et al., 1998), and RF (Konishi, 2013). These 341 
changes in neuromuscular function are suggested to result from the tactile stimulation of the 342 
skin (Konishi, 2013), rather than by the actual tape configuration or alterations in patellar 343 
positioning (Bockrath et al., 1993). Conversely, several other studies have observed no 344 
effect from therapeutic taping on neuromuscular function (Halski et al., 2015, Lins et al., 345 
2013), with little evidence supporting improved athletic performance or muscle strength 346 
(Csapo and Alegre, 2015, Lins et al., 2013). Our results support the hypothesis that applying 347 
KTT across the knee stimulates VM activation and increases the VM-to-VL ratio in 348 
asymptomatic elite cyclists during submaximal efforts, without inducing significant or clear 349 
changes in knee biomechanics. 350 
 351 
The VM muscle is the dynamic medial stabilizer of the patella and functionally important in 352 
aligning the patella within the patella-femoral joint trochlea, which cannot be readily 353 
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examined using skin-markers and 3D motion capture. Our KTT application had no 354 
mechanical intent, and the altered muscle activation seen here most likely resulted from the 355 
enhanced tactile input that altered the excitability of the central nervous system and 356 
modulated proprioceptive afferent feedback loops (Simoneau et al., 1997). The enhanced 357 
VM activation seen in our cyclists when wearing KTT could be beneficial for preventing 358 
patellofemoral pain given that VM is important for the dynamic alignment of the patella. 359 
Studies have shown that individuals with PFP exhibit lower activity levels of all vastus 360 
muscles during walking (Powers et al., 1996) and VM-to-VL ratios across a range of 361 
functional and isometric contraction tasks (Souza and Gross, 1991). Furthermore, delayed 362 
onset of EMG activity of the VM in relation to VL (-0.67 ms) has been identified as a 363 
contributing factor to the development of PFP in one prospective study (Van Tiggelen et al., 364 
2009). That said, prospective studies on this topic in elite cyclists are needed to confirm the 365 
prophylactic effect of patella KTT on knee injury occurrence in this population group. 366 
 367 
Although the VM and VL muscles play a critical role in power output during cycling, there 368 
is also a high activation of the RF and BF muscles (Akima et al., 2005), with proper co-369 
activation of the hamstrings, which has been suggested to reduce stress at the knee during 370 
cycling (So et al., 2005). Hence, reducing the RF-to-BF ratio may have meaningful clinical 371 
implications for athletes who exhibit imbalances between knee extensor and flexor strength, 372 
poor coordination, and non-optimal activation patterns (i.e., athletes who are quadriceps 373 
dominant). With KTT application; there was a clear, likely, and significant decrease in mean 374 
BF signals on the dominant side, as well as and peak and mean RF-to-BF ratio values at 100 375 
W on the non-dominant side; with only a small non-significant decrease in RF-to-BF mean 376 
observed at 200 W. Despite our results indicating some potential for alterations in RF-to-BF 377 
muscle activation patterns, larger sample sizes would be needed to confirm outcomes and 378 
implications of these changes.  379 
 380 
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Most of the neuromuscular effects observed at 100 W became unclear and non-significant at 381 
200 W, pointing to an interaction effect between power output and neuromuscular responses 382 
to taping. It is well established that muscle contraction forces increase primarily due to an 383 
increase in the number of motor units active and associated firing rates in a non-linear 384 
fashion (Merletti and Parker, 2004), with previous cycling studies showing progressive 385 
increase in muscle activation with progressive loads from ~150, 220, 290, and 370 W 386 
(Carpes et al., 2010a). It is plausible that the effect of KTT on the neuromuscular control 387 
diminished with increased overall muscle recruitment, explaining the attenuated effects of 388 
KTT at 200 W; however, the underlying mechanisms are unclear given the paucity of 389 
literature investigating the effect of KTT at different contraction levels and loads within a 390 
given exercise.  391 
 392 
The non-dominant and dominant holistically demonstrated comparable responses to KTT, 393 
although some clear effects and significant findings were only detected on one side. This 394 
discrepancy might be linked to preferred movement patterns of our cyclists, previous injuries 395 
with residual neuromuscular inhibition or muscle weakness, or our limited sample size that 396 
reduced our statistical power. Most studies suggest that bilateral pedalling asymmetries in 397 
terms of power, work, or force increase as the workload decreases (Carpes et al., 2010b), 398 
which might explain some of the differential responses between legs that were observed. 399 
However, given that work was controlled, and power and force not monitored, the 400 
mechanistic reasons behind the between-leg differences remain undetermined.  401 
 402 
Perception 403 
Applying RockTape™ to the anterior aspects of the arms and legs and posterior aspects of 404 
the neck and back has previously been shown to decrease ‘overall’ and ‘chest’ ratings of 405 
perceived exertion of trained cyclists, but not alter ‘arm’ and ‘leg’ ratings of perceived 406 
exertions or gross efficiency (Miller et al., 2015). The physiological findings from this same 407 
investigation were unable to support improved athletic performance with RockTape™ use 408 
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(Miller et al., 2015). Although most of our cyclists perceived additional knee stability and 409 
enhanced performance with KTT; the biomechanical and physiological findings were unable 410 
to support that KTT improved knee stability or economy, with KTT application exerting 411 
unclear, non-significant, or clearly trivial effects on knee ROM and physiological measures. 412 
It is likely that our cyclists’ perceptions result from the EMG changes observed or a placebo 413 
effect (Mak et al., 2018). Nonetheless, KTT application may still provide some benefits to 414 
certain cyclists given the changes observed in the EMG parameters, notably the increased 415 
VM activation and alterations in the VM-to-VL and RF-to-BF activation ratios. 416 
 417 
Individual responses 418 
One cyclist perceived KTT as uncomfortable and decreasing knee stability. Nonetheless, this 419 
particular cyclist felt that KTT improved his performance. This cyclist’s data indicated a 420 
slight worsening in cycling economy measures at 200 W, with a general increase in knee 421 
ROM in all planes of motion with KTT. Simultaneously, EMG signals for VM, VL, and RF, 422 
and the VM-to-VL and RF-to-BF ratios increased with KTT, and decreased for BF. In this 423 
particular case, perceptions matched well with biomechanical findings, but not necessarily 424 
with the physiological ones. In contrast, several cyclists who perceived an increased knee 425 
stability, an improved performance, and felt comfortable with KTT application showed 426 
‘negative’ responses, with their perceptual ratings disagreeing with their objective measures. 427 
Hence, although individual data suggest the presences of ‘positive responders’, ‘negative 428 
responders’, and ‘non-responders’, we were unable to clearly define subgroups from the 429 
subjective data collected.  430 
 431 
Limitations 432 
Small sample sizes are an inherent limitation in any high performance sport environment, 433 
which reduced our statistical power. All male National Team cyclists available for testing 434 
accepted to participate. Our sample size could not be increased further without 435 
compromising the external validity of our findings (i.e., testing lower-level cyclists).  Future 436 
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research should examine the repeatability of the effect of KTT application and the potential 437 
for any long-term effect or habituation to KTT more thoroughly. We tested only elite male 438 
cyclists since the national-level female cyclists were training overseas at the time of data 439 
collection and thus the findings may be specific to this population. Female athletes differ 440 
physiologically, morphologically, and with respect to injury risk factors compared to male 441 
athletes, therefore specific investigations of how female cyclists respond to KTT are 442 
warranted. We also acknowledge that the power settings selected were submaximal for elite 443 
cyclists and that responses at higher powers might differ. Using lower powers was a 444 
necessity to calculate steady state oxygen consumption, economy, and efficiency, and for 445 
practical relevance to the National Cycling Team of Malaysia. It should be noted however, 446 
that during tour events cyclists often perform for prolonged periods at relatively low levels 447 
of power production. For example, Alexander Kristoff’s average power output during the 448 
first hour of Stage 4 of the 2017 Tour de France was 118 W and his average power output 449 
over the entire 4:53:54 of the stage (in which he finished second), was 189 W 450 
(www.trainingpeaks.com). Finally, given the minimalist taping technique applied, it was not 451 
possible to implement a “placebo” taping method or different taping configurations to confer 452 
differences in proprioceptive input. 453 
 454 
CONCLUSIONS 455 
Most cyclists perceived increased performance and knee stability with patella KTT, but the 456 
intervention had little impact on physiological measures and mostly trivial non-significant 457 
effects on knee ROM values. However, patella KTT decreased ROM at the pelvis and trunk 458 
at the higher power and appeared to stabilize the segments proximally, which could be a 459 
favourable adaptation in cyclists (McDaniel et al., 2005). KTT application did alter EMG 460 
responses, notably increasing VM activation and altering the VM-to-VL activation ratio at 461 
100 and 200 W, and changes indicating an increase in BF recruitment in relation to RF at 462 
100 W. Our findings imply that there is a potential for patella KTT to alter neuromuscular 463 
recruitment patterns in elite uninjured cyclists, which could have implications for injury 464 
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prevention and especially the development of PFP by assisting with patella alignment and 465 
alleviating knee-joint stress through neuromuscular pathways as opposed to altering knee 466 
biomechanics. As such, the neuromuscular changes we observed indicate that cyclists may 467 
benefit acutely from patella KTT, although the longitudinal effects of KTT use have not yet 468 
been established.  469 
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Table 1. Mean ± SD values for oxygen cost (mL/kg/km), energy cost (kcal/kg/km), cycling 583 
economy (W/L/min), heart rate (bpm), and gross efficiency (%) in the No Tape (NT) and 584 
Kinesiology-Type Tape (KTT) conditions during the 100 and 200 W cycling efforts. Delta 585 
efficiency (%) in NT and KTT conditions is also presented. Differences between conditions 586 
are expressed using mean change (Δmean); standardized effect size (ES); and paired t-test 587 
statistical significance values (P). Thresholds for clear ES are provided (trivial, small, large, 588 
and very large) and significant changes (P ≤ 0.05) are highlighted in grey.   589 
Parameters  NT KTT Δmean ES (threshold) P 
  100 W 
Oxygen cost   175.4 ± 30.6 175.2 ± 33.5 -0.2 ± 14.1 -0.01 ± 0.42  (unclear) 0.963 
Energy cost   0.86 ± 0.15 0.86 ± 0.16 0.001 ± 0.07 0.001 ± 0.43 (unclear) 0.993 
Economy  53.4 ± 5.6 53.6 ± 5.5 0.2 ± 4.5 0.03 ± 0.78 (unclear) 0.885 
Heart rate  115.3 ± 9.8 115.6 ± 9.5 0.3 ± 5.8 0.03 ± 0.58 (unclear) 0.845 
Gross efficiency  15.5 ± 1.6 15.6 ± 1.6 0.04 ± 1.31 0.02 ± 0.79 (unclear) 0.926 
  200 W 
Oxygen cost   277.3 ± 48.0 273.4 ± 46.1 -3.9 ± 12.6 -0.08 ± 0.26 (trivial)§ 0.311 
Energy cost   1.37 ± 0.23 1.35 ± 0.22 -0.02 ± 0.06 -0.09 ± 0.26 (trivial)§ 0.263 
Economy  67.4 ± 5.2 68.4 ± 5.9 1.0 ± 3.1 0.19 ± 0.54 (trivial) 0.303 
Heart rate  147.6 ± 9.2 146.8 ± 8.4 -0.8 ± 6.4 -0.08 ± 0.70 (unclear) 0.691 
Gross efficiency  19.5 ± 1.5 19.8 ± 1.7 0.3 ± 0.9 0.21 ± 0.54 (small) 0.260 
Delta efficiency  26.5 ± 3.1 27.3 ± 2.3 0.8 ± 3.0 0.25 ± 1.04 (unclear) 0.380 
Note. An effect was deemed ‘unclear’ when its 90% confidence limit overlapped the 590 
thresholds for small positive and small negative effects (i.e., 5%). §Probability of the effect 591 
exceeds 75% and is ‘likely’ to be clinically meaningful.  592 
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Table 2. Mean ± SD values for range of motion values (°) in the sagittal (X), coronal (Y), 593 
and transverse (Z) planes in the No Tape (NT) and Kinesiology-Type Tape (KTT) 594 
conditions during the 100 W cycling efforts for the dominant (D) and non-dominant (ND) 595 
sides. Differences between conditions are expressed using mean change (Δmean); standardized 596 
effect size (ES); and paired t-test statistical significance values (P). Thresholds for clear ES 597 
are provided (trivial, small, large, and very large) and significant changes (P ≤ 0.05) are 598 
highlighted in grey.   599 
Joint Side Plane  NT KTT Δmean ES P 
Ankle 
ND 
X  19.5 ± 8.1 19.9 ± 8.7 0.4 ± 2.1 0.05 (trivial)§ 0.517 
Y  5.3 ± 1.7 5.5 ± 1.9 0.2 ± 0.6 0.11 (trivial)§ 0.289 
Z  5.7 ± 2.3 5.7 ± 1.9 0.0 ± 1.5 0.02 (unclear) 0.920 
D 
X  21.4 ± 4.9 20.3 ± 6.0 -1.1 ± 3.9 -0.22 (small) 0.355 
Y  4.3 ± 1.8 5.0 ± 1.7 0.6 ± 1.2 0.35 (small)§ 0.097 
Z  5.5 ± 0.7 5.2 ± 1.0 -0.3 ± 1.1 -0.44 (unclear) 0.350 
Knee 
ND 
X  76.7 ± 3.1 76.2 ± 3.6 -0.5 ± 1.5 -0.16 (trivial) 0.270 
Y  9.2 ± 3.6 9.0 ± 3.3 -0.2 ± 1.5 -0.04 (trivial)§ 0.727 
Z  9.2 ± 4.9 9.3 ± 3.9 0.1 ± 2.6 0.03 (unclear) 0.867 
D 
X  78.8 ± 2.3 78.2 ± 2.2 -0.5 ± 1.7 -0.23 (small) 0.304 
Y  8.3 ± 2.6 8.1 ± 2.3 -0.2 ± 1.1 -0.08 (trivial)§ 0.526 
Z  12.3 ± 5.3 12.4 ± 4.7 0.0 ± 1.8 0.003 (trivial)§ 0.976 
Hip 
ND 
X  48.7 ± 3.5 48.8 ± 3.8 0.1 ± 1.5 0.02 (unclear) 0.901 
Y  6.3 ± 3.4 6.2 ± 2.8 0.0 ± 1.3 -0.01 (trivial)§ 0.915 
Z  11.5 ± 3.8 11.4 ± 4.3 0.0 ± 1.8 -0.01 (unclear) 0.937 
D 
X  47.5 ± 2.9 47.4 ± 2.8 - 0.1 ± 1.1 -0.04 (trivial)§ 0.694 
Y  6.6 ± 1.8 6.6 ± 1.9 0.0 ± 1.4 -0.005 (unclear) 0.983 
Z  10.0 ± 3.7 9.5 ± 3.2 - 0.5 ± 1.4 -0.12 (trivial) 0.283 
Pelvis 
X  8.1 ± 1.8 8.3 ± 2.2 0.2 ± 1.4 0.10 (unclear) 0.647 
Y  3.5 ± 0.9 3.6 ± 1.1 0.1 ± 0.5 0.09 (trivial) 0.561 
Z  3.7 ± 1.9 3.6 ± 1.3 - 0.1 ± 2.2 -0.05 (unclear) 0.881 
Trunk 
X  8.8 ± 3.9 10.1 ± 8.2 1.3 ± 8.9 0.34 (unclear) 0.620 
Y  0.8 ± 0.2 0.7 ± 0.2 0.0 ± 0.1 -0.07 (trivial)§ 0.643 
Z  8.4 ± 4.1 9.6 ± 8.5 1.2 ± 9.4 0.30 (unclear) 0.663 
Notes. Sagittal (X): ankle dorsiflexion and plantar flexion, knee and hip flexion and 600 
extension, pelvis and trunk anterior and posterior tilt; Coronal (Y): ankle inversion and 601 
eversion, knee valgus and varus, hip abduction and adduction, pelvis and trunk non-602 
dominant side and dominant side tilt; Transverse (Z) ankle, knee, and hip internal and 603 
external rotation, pelvis and trunk non-dominant side and dominant side rotation. An effect 604 
was deemed ‘unclear’ when its 90% confidence limit overlapped the thresholds for small 605 
positive and small negative effects (i.e., 5%). §Probability of the effect exceeds 75% and is 606 
‘likely’ to be clinically meaningful.  607 
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Table 3. Mean ± SD values for range of motion values (°) in the sagittal (X), coronal (Y), 608 
and transverse (Z) planes in the No Tape (NT) and Kinesiology-Type Tape (KTT) 609 
conditions during the 200 W cycling efforts for the dominant (D) and non-dominant (ND) 610 
sides. Differences between conditions are expressed using mean change (Δmean); standardized 611 
effect size (ES); and paired t-test statistical significance values (P). Thresholds for clear ES 612 
are provided (trivial, small, large, and very large) and significant changes (P ≤ 0.05) are 613 
highlighted in grey.   614 
Joint Side Plane  NT KTT Δmean ES P 
Ankle 
ND 
X  21.7 ± 7.8 22.7 ± 8.3 1.0 ± 2.6 0.12 (trivial)§ 0.235 
Y  5.9 ± 2.0 6.2 ± 2.6 0.2 ± 1.0 0.11 (trivial) 0.450 
Z  5.9 ± 1.8 5.7 ± 1.9 -0.2 ± 1.0 -0.11 (trivial) 0.529 
D 
X  24.0 ± 6.9 24.7 ± 5.7 0.7 ± 3.0 0.10 (trivial)§ 0.435 
Y  4.7 ± 1.3 4.9 ± 1.5 0.2 ± 0.6 0.14 (trivial) 0.342 
Z  6.0 ± 1.6 5.8 ± 1.7 -0.2 ± 0.4 -0.14 (trivial)§ 0.123 
Knee 
ND 
X  78.4 ± 3.7 78.9 ± 3.1 0.5 ± 1.7 0.14 (trivial) 0.302 
Y  8.3 ± 2.6 8.2 ± 2.6 -0.7 ± 1.4 -0.03 (unclear) 0.849 
Z  9.4 ± 4.1 8.8 ± 3.1 -0.6 ± 1.8 -0.14 (trivial) 0.277 
D 
X  80.1 ± 2.3 80.9 ± 2.5 0.8 ± 2.1 0.34 (small) 0.224 
Y  7.7 ± 2.1 8.1 ± 2.1 0.4 ± 0.9 0.19 (trivial) 0.146 
Z  11.5 ± 4.5 11.2 ± 4.5 -0.3 ± 1.6 -0.07 (trivial)§ 0.496 
Hip 
ND 
X  49.6 ± 3.9 49.3 ± 4.5 -0.9 ± 2.1 -0.07 (unclear) 0.661 
Y  7.4 ± 3.7 7.4 ± 3.4 0.0 ± 1.0 0.001 (trivial)§ 0.988 
Z  11.5 ± 3.4 12.1 ± 3.4 0.6 ± 1.7 0.18 (trivial) 0.245 
D 
X  47.4 ± 2.8 47.5 ± 2.4 0.1 ± 1.4 0.02 (unclear) 0.874 
Y  7.1 ± 2.5 6.9 ± 2.2 -0.3 ± 1.2 -0.10 (trivial) 0.490 
Z  10.3 ± 3.1 10.4 ± 3.2 0.1 ± 1.5 0.03 (unclear) 0.812 
Pelvis 
X  8.4 ± 2.4 7.9 ± 2.2 -0.5 ± 1.1 -0.19 (trivial) 0.178 
Y  3.5 ± 1.3 3.7 ± 1.5 0.2 ± 0.5 0.14 (trivial) 0.269 
Z  4.0 ± 1.8 3.6 ± 1.1 -0.4 ± 1.8 -0.22 (unclear) 0.447 
Trunk 
X  9.5 ± 4.2 8.6 ± 2.7 -0.9 ± 3.4 -0.21 (unclear) 0.391 
Y  0.9 ± 0.5 0.9 ± 0.3 0.0 ± 0.3 -0.04 (unclear) 0.834 
Z  8.6 ± 3.8 7.8 ± 2.6 -0.9 ± 3.6 -0.22 (unclear) 0.430 
Notes. Sagittal (X): ankle dorsiflexion and plantar flexion, knee and hip flexion and 615 
extension, pelvis and trunk anterior and posterior tilt; Coronal (Y): ankle inversion and 616 
eversion, knee valgus and varus, hip abduction and adduction, pelvis and trunk non-617 
dominant side and dominant side tilt; Transverse (Z) ankle, knee, and hip internal and 618 
external rotation, pelvis and trunk non-dominant side and dominant side rotation. An effect 619 
was deemed ‘unclear’ when its 90% confidence limit overlapped the thresholds for small 620 
positive and small negative effects (i.e., 5%). §Probability of the effect exceeds 75% and is 621 
‘likely’ to be clinically meaningful. 622 
623 
26 
 
Table 4. Mean (%max), peak (%max), and integrated EMG (iEMG, %max) signal values (mean 624 
± SD) for the vastus medialis (VM), vastus lateralis (VL), rectus femoris (RF), and biceps 625 
femoris (BF) muscles in the No Tape (NT) and Kinesiology-Type Tape (KTT) conditions 626 
during the 100 W cycling efforts for the dominant (D) and non-dominant (ND) sides. The 627 
VM-to-VL and RF-to-BF activation ratios are also presented. Differences between 628 
conditions are expressed using mean change (Δmean); standardized effect size (ES); and 629 
paired t-test statistical significance values (P). Thresholds for clear ES are provided (trivial, 630 
small, large, and very large) and significant changes (P ≤ 0.05) are highlighted in grey.   631 
Muscle Side EMG  NT KTT Δmean ES (threshold) P 
  Peak  29.5 ± 5.9 37.4 ± 5.1 8.0 ± 7.4 1.35 (large)§ 0.047 
 ND iEMG  39.9 ± 10.1 47.3 ± 7.9 7.3 ± 9.9 0.72 (moderate)§ 0.128 
VM  Mean  9.4 ± 1.7 9.2 ± 2.6 -0.2 ± 2.6 -0.13 (unclear) 0.840 
  Peak  31.4 ± 9.3 39.5 ± 8.0 8.1 ± 10.1 0.87 (moderate)§ 0.056 
 D iEMG  38.1 ± 11.9 49.7 ± 16.0 11.7 ± 8.9 0.98 (moderate)§ 0.024 
  Mean  7.9 ± 2.1 9.9 ± 2.2 2.0 ± 2.1 0.95 (moderate)§ 0.030 
  Peak  39.3 ± 11.0 36.8 ± 8.0 -2.5 ± 15.8 -0.23 (unclear) 0.717 
 ND iEMG  47.3 ± 11.0 36.8 ± 8.0 -0.5 ± 18.0 -0.05 (unclear) 0.950 
VL  Mean  9.4 ± 1.7 9.2 ± 2.6 -0.2 ± 2.6 -0.13 (unclear) 0.840 
  Peak  37.0 ± 5.4 36.9 ± 8.2 -0.2 ± 10.0 -0.03 (unclear) 0.965 
 D iEMG  44.7 ± 10.1 47.2 ± 12.4 2.5 ± 10.2 0.25 (unclear) 0.545 
  Mean  8.7 ± 1.8 9.0 ± 2.4 0.2 ± 1.8 0.13 (unclear) 0.725 
  Peak  24.7 ± 4.5 22.7 ± 2.5 -2.0 ± 5.7 -0.44 (unclear) 0.482 
 ND iEMG  35.1 ± 6.8 33.0 ± 4.4 -2.1 ± 4.8 -0.30 (unclear) 0.391 
RF  Mean  7.5 ± 1.0 7.0 ± 0.6 -0.6 ± 1.0 -0.54 (unclear) 0.279 
  Peak  29.6 ± 11.0 25.2 ± 8.7 -4.3 ± 4.3 -0.39 (small)§ 0.135 
 D iEMG  39.0 ± 10.0 36.1 ± 5.8 -3.0 ± 4.6 -0.30 (unclear) 0.287 
  Mean  7.3 ± 1.3 6.7 ± 0.7 -0.7 ± 0.6 -0.51 (small)§ 0.137 
  Peak  37.2 ± 11.9 39.2 ± 8.6 1.9 ± 6.0 0.16 (unclear) 0.514 
 ND iEMG  42.8 ± 11.7 42.8 ± 6.7 -0.9 ± 9.3 -0.08 (unclear) 0.830 
BF  Mean  7.9 ± 2.0 8.4 ± 1.5 0.5 ± 1.1 0.25 (unclear) 0.351 
  Peak  42.0 ± 5.2 38.5 ± 3.3 -3.5 ± 3.2 -0.67 (moderate)§ 0.120 
 D iEMG  42.7 ± 5.1 40.7 ± 4.7 -2.1 ± 3.3 -0.41 (unclear) 0.303 
  Mean  7.6 ± 1.3 7.4 ± 1.4 -0.6 ± 0.3 -0.36 (small)§ 0.044 
  Peak  81.6 ± 8.0 99.2 ± 12.2 17.6 ± 19.8 2.20 (very large)§ 0.118 
 ND iEMG  82.2 ± 16.0 102.4 ± 18.3 20.1 ± 24.2 1.26 (large)§ 0.097 
VM:VL  Mean  76.8 ± 11.0 95.4 ± 14.2 18.6 ± 22.8 0.95 (moderate)§ 0.088 
  Peak  75.1 ± 14.7 107.2 ± 29.2 32.1 ± 18.8 2.19 (large)§ 0.009 
 D iEMG  84.9 ± 14.0 107.7 ± 26.0 22.8 ± 16.6 1.63 (large)§ 0.020 
  Mean  91.9 ± 19.6 115.6 ± 27.7 23.7 ± 23.4 1.21 (large)§ 0.029 
  Peak  68.0 ± 21.8 58.8 ± 18.7 -9.1 ± 6.5 -0.42 (small)§ 0.021 
 ND iEMG  85.6 ± 19.8 80.7 ± 16.0 -5.0 ± 13.1 -0.25 (unclear) 0.445 
RF:BF  Mean  99.5 ± 22.8 85.5 ± 17.2 -14.0 ± 7.8 -0.62 (moderate)§ 0.016 
  Peak  69.5 ± 18.8 65.4 ± 20.2 -4.1 ± 8.1 -0.22 (unclear) 0.388 
 D iEMG  91.6 ± 23.6 89.5 ± 18.2 -2.1 ± 5.7 -0.09 (trivial) 0.514 
  Mean  93.9 ± 23.6 91.6 ± 18.2 -2.3 ± 5.5 -0.10 (trivial) 0.456 
Note. An effect was deemed ‘unclear’ when its 90% confidence limit overlapped the 632 
thresholds for small positive and small negative effects (i.e., 5%). An effect was deemed 633 
‘unclear’ when its 90% confidence limit overlapped the thresholds for small positive and 634 
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small negative effects (i.e., 5%). §Probability of the effect exceeds 75% and is ‘likely’ to be 635 
clinically meaningful.  636 
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Table 5. Mean (%max), peak (%max), and integrated EMG (iEMG, %max) signal values (mean 637 
± SD) for the vastus medialis (VM), vastus lateralis (VL), rectus femoris (RF), and biceps 638 
femoris (BF) muscles in the No Tape (NT) and Kinesiology-Type Tape (KTT) conditions 639 
during the 200 W cycling efforts for the dominant (D) and non-dominant (ND) sides. The 640 
VM-to-VL and RF-to-BF activation ratios are also presented. Differences between 641 
conditions are expressed using mean change (Δmean); standardized effect size (ES); and 642 
paired t-test statistical significance values (P). Thresholds for clear ES are provided (trivial, 643 
small, large, and very large) and significant changes (P ≤ 0.05) are highlighted in grey.   644 
Muscle Side EMG  NT KTT Δmean ES (threshold) P 
  Peak  39.4 ± 9.4 48.0 ± 4.4 8.6 ± 12.7 0.92 (moderate)§ 0.122 
 ND iEMG  58.2 ± 9.6 68.1 ± 5.7 9.9 ± 7.7 1.04 (moderate)§ 0.014 
VM  Mean  10.7 ± 1.5 12.1 ± 1.8 1.4 ± 1.8 0.92 (moderate)§ 0.088 
  Peak  47.0 ± 9.4 48.2 ± 5.3 1.2 ± 10.9 0.13 (unclear) 0.741 
 D iEMG  69.1 ± 10.7 70.1 ± 6.2 1.0 ± 11.4 0.09 (unclear) 0.830 
  Mean  13.0 ± 2.4 14.1 ± 1.7 1.1 ± 3.0 0.46 (unclear) 0.380 
  Peak  46.4 ± 9.5 47.7 ± 6.2 1.3 ± 12.4 0.13 (unclear) 0.797 
 ND iEMG  66.4 ± 6.9 68.9 ± 11.5 2.5 ± 13.7 0.37 (unclear) 0.643 
VL  Mean  12.8 ± 1.8 12.8 ± 3.2 0.1 ± 2.2 0.05 (unclear) 0.924 
  Peak  50.2 ± 7.0 47.7 ± 9.0 -2.6 ± 9.3 -0.37 (unclear) 0.433 
 D iEMG  65.8 ± 8.1 69.4 ± 9.0 3.6 ± 9.4 0.45 (unclear) 0.284 
  Mean  13.0 ± 1.6 13.1 ± 2.1 0.1 ± 1.7 0.09 (unclear) 0.831 
  Peak  34.4 ± 12.6 37.1 ± 2.5 2.8 ± 14.5 0.22 (unclear) 0.657 
 ND iEMG  54.4 ± 15.9 53.7 ± 6.7 -0.7 ± 15.1 -0.04 (unclear) 0.906 
RF  Mean  11.9 ± 3.0 11.9 ± 1.7 -0.1 ± 3.4 -0.02 (unclear) 0.971 
  Peak  39.5 ± 10.1 40.8 ± 6.6 1.3 ± 7.2 0.13 (unclear) 0.672 
 D iEMG  62.1 ± 11.9 63.7 ± 7.8 1.6 ± 13.6 0.14 (unclear) 0.761 
  Mean  11.6 ± 1.7 11.4 ± 1.8 -0.2 ± 2.2 -0.11 (unclear) 0.844 
  Peak  42.6 ± 11.6 45.1 ± 6.4 2.6 ± 16.0 0.22 (unclear) 0.711 
 ND iEMG  57.8 ± 12.9 58.8 ± 8.7 1.0 ± 12.9 0.08 (unclear) 0.846 
BF  Mean  12.7 ± 4.8 12.2 ± 3.0 -0.5 ± 3.7 -0.11 (unclear) 0.735 
  Peak  44.1 ± 8.1 38.5 ± 5.9 -5.6 ± 6.2 -0.69 (moderate)§ 0.077 
 D iEMG  52.8 ± 13.1 52.8 ± 6.8 0.0 ± 13.4 -0.01 (unclear) 0.999 
  Mean  10.7 ± 3.1 9.6 ± 2.1 -1.0 ± 2.4 -0.34 (unclear) 0.338 
  Peak  85.6 ± 8.5 97.6 ± 15.5 11.9 ± 17.6 1.41 (large)§ 0.157 
 ND iEMG  87.8 ± 12.8 101.5 ± 20.9 13.7 ± 20.3 0.88 (moderate)§ 0.124 
VM:VL  Mean  84.6 ± 6.8 98.7 ± 21.5 14.2 ± 19.2 2.07 (very large)§ 0.098 
  Peak  94.8 ± 19.3 98.5 ± 19.8 3.8 ± 27.2 0.20 (unclear) 0.707 
 D iEMG  96.6 ± 20.9 104.4 ± 18.3 7.8 ± 23.1 0.37 (unclear) 0.340 
  Mean  100.2 ± 13.1 110.8 ± 27.9 10.6 ± 25.2 0.80 (unclear) 0.311 
  Peak  82.6 ± 24.3 83.3 ± 9.7 0.7 ± 30.6 0.03 (unclear) 0.955 
 ND iEMG  98.3 ± 34.4 92.9 ± 18.2 -5.3 ± 27.1 -0.16 (unclear) 0.620 
RF:BF  Mean  120.1 ± 34.2 106.7 ± 16.2 -13.4 ± 19.2 -0.39 (small)§ 0.194 
  Peak  92.5 ± 27.2 106.8 ± 17.0 14.3 ± 24.7 0.53 (unclear) 0.214 
 D iEMG  124.1 ± 36.9 121.5 ± 15.1 -2.7 ± 40.3 -0.07 (unclear) 0.867 
  Mean  118.3 ± 43.9 121.8 ± 27.7 3.6 ± 37.6 0.09 (unclear) 0.825 
Note. An effect was deemed ‘unclear’ when its 90% confidence limit overlapped the 645 
thresholds for small positive and small negative effects (i.e., 5%). §Probability of the effect 646 
exceeds 75% and is ‘likely’ to be clinically meaningful.  647 
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Figure captions 648 
 649 
Figure 1. Cyclist set-up for data collection with the patella kinesiology-type tape (KTT) 650 
applied. 651 
 652 
Figure 2. Marker placement for 3D motion capture from anterior (left), posterior (middle), 653 
and lateral (right) views. Anatomical reference markers were placed bilaterally on the 654 
acromial processes, anterior superior iliac spines, posterior superior iliac spines, greater 655 
trochanters, medial and lateral femoral epicondyles, medial and lateral malleoli, and 1st and 656 
5th metatarsal heads. Tracking markers were placed bilaterally on the heel, mid-foot, and 657 
forefoot, and 4-marker rigid clusters were placed on the lateral aspect of the pelvis and 658 
bilaterally on the lateral aspects of the thighs and shanks. Anterior superior iliac spine, 659 
greater trochanter, femoral epicondyle, malleolus, and 1st metatarsal head markers were 660 
removed before the dynamic cycling efforts (red circles). 661 
 662 
Figure 3. Ratings of comfort levels and perceived change in knee stability and cycling 663 
performance with the application of kinesiology-type tape (KTT) compared to no tape (NT) 664 
on a 5-point Likert scale. Data presented are the number of cyclists (n) that provided a given 665 
rating. Comfort level: 1, very uncomfortable; 2, uncomfortable; 3, no change; 4, 666 
comfortable; 5, very comfortable. Knee stability: 1, much less stable; 2, less stable; 3, no 667 
change; 4, more stable; 5, much more stable. Performance: 1, much worse; 2, worse; 3, no 668 
change; 4, better; 5, much better. 669 
